Pro-life groups urge Kennedy, FDA to restore guarantees of abortions removed under Biden

NEWYou can now listen to Fox News articles!
First on Fox: While Planned Parenthood continued the Trump administration for the provisions of the “large and beautiful bill”, the financing of abortion suppliers, pro-life medical groups urged the secretary of health and social services Robert F. Kennedy Jr. to re-examine the broad approval by the FDA of drug drugs.
In a letter obtained by Fox News Digital, six anti-abortion medical organizations, representing around 30,000 health professionals, urges Kennedy and the FDA commissioner, Martin Makary, to reintegrate security guards into the abortion pill, which has been deleted since his first approved in 2000.
According to the Guttmacher Institute, drug abortion represents 63% of all American abortions. The most common form of the drug abortion method is to ingest mifepristone, a pill that cuts off the flux of progesterone towards the uterus, essentially samping the fetus of nutrients. A second pill, called Misoprostol, is then ingested to expel the dead fetus.
Under the Biden Administration, the FDA has considerably widened its approval from mifepristone, making it possible to obtain the drugs by telemedicine, without an appointment with the doctor in person and to be sent by post.
Biden’s appointed judge interrupts Trump HHS Revision after the Democrats trial

Left: the secretary of HHS, Robert F. Kennedy Jr. on the right: abortion pills, known as Miffepristone, which are now the most common abortion method. (Roy Rochlin / Getty Images and Erin Hooley / Chicago Tribune / Tribune News Service via Getty Images)
In the letter, the groups, including the American Association of Pro-Life Obgyns, the Alliance for Hippocratic Medicine and the American College of Family Medicine, warn that the latest data on mifepristone “strongly suggest” that hundreds of thousands of women have been injured using the drug.
Planned Parenthood declares on its website that chemical abortion is “safer than many other drugs such as penicillin, Tylenol and Viagra”. The letter, however, calls for mifepristone “a high -risk medication in abortion which is known to cause serious undesirable effects and medical emergencies, in particular hemorrhage, sepsis and incomplete abortions requiring surgery”.
The letter quotes two reports published in May, one of the bases of the Restoration of America and the other by the Center for Ethics and Public Policy, which according to them, showed up to one in nine using Miffepristone has undergone serious undesirable events.
Studies have said that, based on an analysis of health insurance files covering 330 million American patients of 860,000 women receiving mifepristone prescriptions, 10.93% of women experienced sepsis, infection, hemorrhage, surgical intervention or other serious adverse event within 45 days of the use of the drug.
HHS brings back hundreds of staff members after reducing force in the last move

Miffepristone (Mifeprex) and Misoprostol, the two drugs used in an abortion of drugs, are observed at the women’s reproduction clinic in Santa Teresa, New Mexico, June 17, 2022. (Robyn Beck / AFP via Getty Images)
On this basis, the letter indicates that the real data on the use of mifepristone “show that real patients are experiencing very real medical emergencies at an alarming rate – a rate in accordance with what our members see in their clinical practice”.
“The data strongly suggests that mifepristone has a much greater risk of harming that previously.
In light of this, AAPLOG and the other groups that register on the letter urges the FDA to carry out its own evaluation of the real world data to determine the overall security of mifepristone in adult and adolescent populations.
The groups also urged Kennedy and Makary to restore reports of all unwanted events related to the use of mifepristone and to restore the evaluation and attenuation strategies before 2016 on the use of the drug, in particular the limitation of the use of the drug to seven weeks of gestation and requiring a dispensation in person as well as follow-up meetings.
The Supreme Wisconsin Court decides on the abortion case which caused the most expensive judicial elections in American history

Miffepristone drug boxes on a shelf at the West Alabama Women’s Center in Tuscaloosa on March 16, 2022.
The letter underlined that requiring ultrasounds is also essential to confirm the gestational age of the fetus, which, according to the groups, is “crucial to precisely date a pregnancy and determine the risk of complications”.
“A basic principle of medical ethics is an informed consent – which requires an examination of the specific risks and advantages of any proposed intervention which is specific to the patient seated before us which is based on real data, and not by rhetoric focused on ideology”, indicates the letter. “Women deserve to know the real risk of serious and medical emergency events after using mifepristone – regardless of the way the discussion was politically responsible for this medication.”
“Americans must be able to believe that whatever happens, the FDA will rely on the most robust safety standards before and after approving any medication and that they may have a really enlightened consent knowing what the risks are taking drugs approved by the FDA,” said the letter.
The large approval by the FDA of Miffepristone has been the subject of an intense legal debate in recent years, especially at the Supreme Court. In 2024, the Supreme Court rejected a case brought by the Alliance for Hippocratic Medicine contesting the approval of the FDA abortion pill on the grounds that the group lacked position.
The Senate parliamentarian prohibits the Federal Planned Parenthood funding in Trump Megabill

The demonstrators meet before the Supreme Court as he hears oral arguments in the case of the US Food and Drug Administration c. Alliance for Hippocratic Medicine on March 26, 2024, in Washington, DC (Anna Rose Layden / Getty Images)
At the time, Dr. Jack Resneck Jr., then president of the American Medical Association, said that the restriction of mifepristone “would have devastating health consequences for people living in states where abortion is still legal”.
Resneck said that “hundreds and hundreds of clinical studies evaluated by peers and decades of research based on evidence refutes the affirmations of the complainants in this case and demonstrate the safety of mifepristone”, which, according to him, “has a safety profile comparable to ibuprofen”.
After the publication of the ethics and public policy report, Dr. Céline Gounder, a medical contributor to CBS News and editor -in -chief for public health at KFF Health News, challenged the results, accusing the study of lack of transparency and not to disclose its data source, according to CBS.
Gounder also said that the study did not have a comparison group to examine how experiences compare to pregnant women who do not take mifepristone.
A Danco spokesperson, the manufacturer of Mifepristone, also declared to the point of sale that the company “is confidently behind the established security and efficiency file”.
The GOP representative is expressed after being forced to evacuate offices on the threats of pro-abortion activists

A group of anti-abortion demonstrators crushes the gathering of action for women’s march for reproduction rights to Mariachi Plaza in Los Angeles on October 8, 2022. (David McNew / AFP via Getty Images)
In a declaration sent by email to Fox News Digital, Dr. Christina Francis, an OB-GYN and CEO of AAPLOG, said that the deregulation of the FDA of Miffepristone “follows pregnant women at an unacceptably low level of care, which leaves them vulnerable to deadly complications and residents.”
Click here to obtain the Fox News app
“Our doctors have seen the devastating impact that this imprecision had on patients, which clearly shows the disastrous need of the FDA to restart women and girls by re-examining the safety of the drug and restoring the basic guarantees that should never have been lifted,” she said.
The other groups that signed the letter are the Christian Medical and Dental Association, the American College of Pediatricians and the Coptic Medical Association of North America.